Search Results - "Greenawalt, Evan J."

Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition by Mitra, Ramkrishna, Chen, Xi, Greenawalt, Evan J., Maulik, Ujjwal, Jiang, Wei, Zhao, Zhongming, Eischen, Christine M.

“…Long non-coding RNA (lncRNA) are emerging as contributors to malignancies. Little is understood about the contribution of lncRNA to epithelial-to-mesenchymal…”
Get full text

IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation by Dowling, John P, Nikitin, Pavel A, Shen, Fang, Shukla, Halley, Finn, James P, Patel, Nirja, Swider, Cezary, Bingaman-Steele, Jamie L, Nicolescu, Chris, Sikorski, Eden L, Greenawalt, Evan J, Morin, Michael J, Robinson, Matthew K, Lundgren, Karen, Harman, Benjamin C

“…Immune checkpoint inhibitors that overcome T cell suppressive mechanisms in tumors have revolutionized the treatment of cancer but are only efficacious in a…”
Get full text

An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma by Teh, Jessica L F, Purwin, Timothy J, Greenawalt, Evan J, Chervoneva, Inna, Goldberg, Allison, Davies, Michael A, Aplin, Andrew E

“…Aberrant cell-cycle progression is a hallmark feature of cancer cells. Cyclin-dependent kinases 4 and 6 (CDK4/6) drive progression through the G1 stage of the…”
Get full text

Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion by Greenawalt, Evan J, Edmonds, Mick D, Jain, Neha, Adams, Clare M, Mitra, Ramkrishna, Eischen, Christine M

“…Metastatic lung cancer is common in patients with lung adenocarcinoma, but the molecular mechanisms of metastasis remain incompletely resolved. miRNA regulate…”
Get full text

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa by Cho, Raymond J, Alexandrov, Ludmil B, den Breems, Nicoline Y, Atanasova, Velina S, Farshchian, Mehdi, Purdom, Elizabeth, Nguyen, Tran N, Coarfa, Cristian, Rajapakshe, Kimal, Prisco, Marco, Sahu, Joya, Tassone, Patrick, Greenawalt, Evan J, Collisson, Eric A, Wu, Wei, Yao, Hui, Su, Xiaoping, Guttmann-Gruber, Christina, Hofbauer, Josefina Piñón, Hashmi, Raabia, Fuentes, Ignacia, Benz, Stephen C, Golovato, Justin, Ehli, Erik A, Davis, Christel M, Davies, Gareth E, Covington, Kyle R, Murrell, Dedee F, Salas-Alanis, Julio C, Palisson, Francis, Bruckner, Anna L, Robinson, William, Has, Cristina, Bruckner-Tuderman, Leena, Titeux, Matthias, Jonkman, Marcel F, Rashidghamat, Elham, Lwin, Su M, Mellerio, Jemima E, McGrath, John A, Bauer, Johann W, Hovnanian, Alain, Tsai, Kenneth Y, South, Andrew P

“…Recessive dystrophic epidermolysis bullosa (RDEB) is a rare inherited skin and mucous membrane fragility disorder complicated by early-onset, highly malignant…”
Get more information

Abstract 5199: An in vivo reporter to quantitatively and temporally analyze the effects of CDK4/6 inhibitor-based therapies in melanoma by Teh, Jessica L., Purwin, Timothy, Greenawalt, Evan J., Chervoneva, Inna, Goldberg, Allison, Davies, Michael E., Aplin, Andrew

“…Abstract Aberrant cell cycle progression is a hallmark feature of cancer cells. Cyclin-dependent kinase 4 and 6 (CDK4/6) drive progression through the G1 stage…”
Get full text

IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation by Dowling, John P., Nikitin, Pavel A., Shen, Fang, Shukla, Halley, Finn, James P., Patel, Nirja, Swider, Cezary, Bingaman-Steele, Jamie L., Nicolescu, Chris, Sikorski, Eden L, Greenawalt, Evan J., Morin, Michael J., Robinson, Matthew K., Lundgren, Karen, Harman, Benjamin C.

“…Immune checkpoint inhibitors that overcome T cell suppressive mechanisms in tumors have revolutionized the treatment of cancer but are only efficacious in a…”
Get full text